为您找到相关结果约500个

你是不是要搜索 期刊Ad26.COV2.S 点击跳转

Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid

S-2 Fluorescence from [26]Hexaphyrin Dianion

Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration

Schwinger mechanism in global d S-2 and Ad S-2 space

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting

Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting

SARS-CoV-2 S Glycoprotein Stabilization Strategies

Better Antibody Response After a Dose of Ad.26.cov2.s vs MRNA Vaccines in Seronegative Transplant RecipientsAfter 2-Dose MRNA Vaccination.

Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects

Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

Ad.26.COV2.S Versus BNT162b2 or mRNA-1273 as a Third Dose in Solid Organ Transplant Recipients SeronegativeAfter 2-dose mRNA Vaccination

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis

Genomic Surveillance for SARS-CoV-2-China, September 26, 2022 to January 29, 2023

Near-Ad S-2 perturbations and the connection with near-extreme Reissner-Nordstrom

为您找到相关结果约500个

共500条页码: 1/34页15条/页